⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

November 20, 2017The OncologistOpen Access

Adverse Event Reporting in Clinical Trials: Time to Include Duration as Well as Severity

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

This editorial discusses flaws in the current system for reporting adverse events.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Oliver A. Sartor (2017) studied this question.

synapsesocial.com/papers/6ab31dbc274437374560d1d8 https://doi.org/10.1634/theoncologist.2017-0437

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1TAVO412, an Anti-EGFR, cMET and VEGF Trispecific Antibody: Initial Results from a Phase I Dose Escalation Study in Patients with Advanced Solid TumorsThe Oncologist · 2026
2Tumor Longevity: a time-dependent biomarker of immune checkpoint inhibitor responsiveness across head and neck, lung, renal and urothelial cancersThe Oncologist · 2026
3National Gaps in Appendiceal Cancer Care and Implementation of a Regional Virtual Multidisciplinary Care ConferenceThe Oncologist · 2026
4Cholesterol transporters and immune-metabolic features in patients with metastatic renal cell carcinoma receiving immunotherapy combinationsThe Oncologist · 2026
5Real-world treatment patterns and survival outcomes in extensive-stage small cell lung cancer across first-line induction and maintenance therapyThe Oncologist · 2026
6Clinical and Molecular Evolution During Panitumumab-Containing Therapy in EGFR-Amplified Esophagogastric AdenocarcinomaThe Oncologist · 2026
7Peri-treatment Creatinine-Based eGFR Trajectories in Patients Receiving Breast Radiotherapy: A Retrospective Cohort StudyThe Oncologist · 2026
8Rethinking Radiation Therapy in the Era of RAS Inhibition for Pancreatic CancerThe Oncologist · 2026
9Gabapentinoids for Oncologic Pruritus: A Retrospective Cohort StudyThe Oncologist · 2026
10Outcomes of Chemoimmunotherapy in Metastatic Pancreatic Neuroendocrine Carcinoma: A Single-Center Clinicopathologic StudyThe Oncologist · 2026

More from The Oncologist

More from Tulane University